Peptide compounds for treating obesity and insulin resistance

Details for Australian Patent Application No. 2008311962 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors MacNeil, Douglas J.; Zhou, Heather H.; Tota, Michael R.; Wang, Fubao; Pinto, Shirly; Chin, Chen-Ni

Agent Spruson & Ferguson

Pub. Number AU-A-2008311962

PCT Pub. Number WO2009/051706

Priority 60/999,274 17.10.07 US

Filing date 14 October 2008

Wipo publication date 23 April 2009

International Classifications

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/051706 Priority application(s): WO2009/051706

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008311971-Quinolizidinone M1 receptor positive allosteric modulators

2008311957-Methods and compositions for printing biologically compatible nanotube composites of autologous tissue